Qinling Qu
About Qinling Qu
Qinling Qu is the Director, Global Regulatory Lead, Oncology at Bristol Myers Squibb, with over 20 years of experience in regulatory affairs within the pharmaceutical industry.
Title and Current Role
Qinling Qu is the Director, Global Regulatory Lead, Oncology at Bristol Myers Squibb. Qinling is based in Princeton, New Jersey, United States, where they focus on leading regulatory strategies for oncology products globally.
Professional Career in Regulatory Affairs
Qinling Qu has more than two decades of experience in regulatory affairs within the pharmaceutical industry. Their career includes significant roles at multiple top pharmaceutical companies. From 2019 to 2021, Qinling served as Director, Global Regulatory Affairs – Oncology at Merck in Upper Gwynedd, PA. Prior to that, Qinling worked at CSL Behring as Global Regulatory Lead from 2017 to 2019, and at Johnson & Johnson as Manager, Regulatory Affairs Oncology from 2013 to 2017.
Education and Expertise in Chemical Engineering and Chemistry
Qinling Qu holds a Master of Science (MS) degree in Chemical Engineering from Purdue University, where they studied from 1997 to 2000. They also have a Bachelor of Science (B.S.) degree in Chemistry from the University of Wisconsin-Eau Claire, achieved between 1995 and 1997. This strong academic background in both chemistry and chemical engineering provides them with a unique perspective in regulatory affairs.
Background in Research and Regulatory Roles
Over the years, Qinling Qu has amassed experience working in both research and regulatory roles, providing a comprehensive understanding of the drug development process. They began their career as a Staff Scientist at DuPont Pharmaceuticals from 2000 to 2002, followed by a role as an Associate Scientist at Pfizer from 2002 to 2003. Additionally, Qinling contributed to Bristol-Myers Squibb as an Associate Research Scientist II from 2003 to 2008, and later specialized in regulatory affairs at Novo Nordisk from 2008 to 2011.
Leadership Roles in Oncology Regulatory Affairs
Qinling Qu has held multiple leadership roles focusing specifically on oncology regulatory affairs. This includes their current position at Bristol Myers Squibb, as well as previous roles at Merck and Johnson & Johnson. Their extensive experience in these leadership positions underscores their expertise in navigating the complexities of regulatory strategies for oncology products.